Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population

Journal of Psychiatric Research

Volumn 43, Issue 9, 2009, Pages 870-876

  Gavin, David P ^a,b   Kartan, Saritha ^a   Chase, Kayla ^a,b   Jayaraman, Sundararajan ^b   Sharma, Rajiv P ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Epigenetic; GAD1; HDAC; Lymphocyte; mRNA; Negative symptoms

Indexed keywords

ARIPIPRAZOLE; DEPAKOTE ER; DIMETHYL SULFOXIDE; GLUTAMATE DECARBOXYLASE 67; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; MESSENGER RNA; OLANZAPINE; RISPERIDONE; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; CELL ISOLATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; EPIGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE CULTURE; MALE; MICROCHIP ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONTENT; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; WESTERN BLOTTING;

EID: 67349238734     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2008.12.006     Document Type: Article

References (34)

1. Abdolmaleky H.M., Cheng K.H., Russo A., Smith C.L., Faraone S.V., Wilcox M., et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. American Journal of Medical Genetics, B, Neuropsychiatric Genetics 134 (2005) 60-66
2. Akbarian S., Ruehl M.G., Bliven E., Luiz L.A., Peranelli A.C., Baker S.P., et al. Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Archives of General Psychiatry 62 (2005) 29-40
3. Akbarian S., and Huang H.S. Molecular and cellular mechanisms of altered GAD67/GAD67 expression in schizophrenia and related disorders. Brain Research Reviews 52 (2006) 293-304
4. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., et al. High-resolution profiling of histone methylations in the human genome. Cell 129 (2007) 823-837
5. Benes F.M., and Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25 (2001) 1-27
6. Costa E., Chen Y., Davis J., Dong E., Noh J.S., Tremolizzo L., et al. Reelin and schizophrenia: a disease at the interface of the genome and the epigenome. Molecular Interventions 2 (2002) 47-57
7. Costa E., Grayson D.R., Mitchell C.P., Tremolizzo L., Veldic M., and Guidotti A. GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability. Critical Reviews in Neurobiology 15 (2003) 121-142
8. Dong E., Guidotti A., Grayson D.R., and Costa E. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proceedings of the National Academy of Sciences USA 104 (2007) 4676-4681
9. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proceedings of the National Academy of Sciences USA 102 (2005) 10604-10609
10. Garcia-Bassets I., Kwon Y.S., Telese F., Prefontaine G.G., Hutt K.R., Cheng C.S., et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128 (2007) 505-518
11. Gavin D.P., Kartan S., Chase K., Grayson D.R., and Sharma R.P. Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. Schizophrenia Research 103 (2008) 330-332
12. Jayaraman S., Castro M., O'Sullivan M., Bragdon M.J., and Holtzman M.J. Resistance to Fas-mediated T cell apoptosis in asthma. Journal of Immunology 162 (1999) 1717-1722
13. Kouzarides T. Chromatin modifications and their function. Cell 128 (2007) 693-705
14. Kumar A., Choi K.H., Renthal W., Tsankova N.M., Theobald D.E., Truong H.T., et al. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48 (2005) 303-314
15. Kundakovic M., Chen Y., Costa E., and Grayson D.R. DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Molecular Pharmacology 71 (2007) 644-653
16. Kuratomi G., Iwamoto K., Bundo M., Kusumi I., Kato N., Iwata N., Ozaki N., and Kato T. Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Molecular Psychiatry 13 (2008) 429-441
17. Li B., Carey M., and Workman J.L. The role of chromatin during transcription. Cell 128 (2007) 707-719
18. Lim J.H., Booker A.B., and Fallon J.R. Regulating fragile X gene transcription in the brain and beyond. Journal of Cell Physiology 205 (2005) 170-175
19. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
20. Mitchell C.P., Chen Y., Kundakovic M., Costa E., and Grayson D.R. Histone deacetylase inhibitors decrease reelin promoter methylation in vitro. Journal of Neurochemistry 93 (2005) 483-492
21. Noh J.S., Sharma R.P., Veldic M., Salvacion A.A., Jia X., Chen Y., et al. DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proceedings of the National Academy of Sciences USA 102 (2005) 1749-1754
22. Petronis A., Gottesman I.I., Kan P., Kennedy J.L., Basile V.S., Paterson A.D., et al. Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance?. Schizophrenia Bulletin 29 (2003) 169-178
23. Petronis A. The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis. Biological Psychiatry 55 (2004) 965-970
24. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., and Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. Journal of Biological Chemistry 276 (2001) 36734-36741
25. Shahbazian M.D., and Grunstein M. Functions of Site-Specific Histone Acetylation and Deacetylation. Annual Reviews in Biochemistry 76 (2007) 75-100
26. Sharma R.P. Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics. Schizophrenia Research 72 (2005) 79-90
27. Sharma R.P., Rosen C., Kartan S., Guidotti A., Costa E., Grayson D.R., et al. Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population. Schizophrenia Research 88 (2006) 227-231
28. Simonini M.V., Camargo L.M., Dong E., Maloku E., Veldic M., Costa E., et al. The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proceedings of the National Academy of Sciences USA 103 (2006) 1587-1592
29. Torrey E.F., Barci B.M., Webster M.J., Bartko J.J., Meador- Woodruff J.H., and Knable M.B. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biological Psychiatry 57 (2005) 252-260
30. Tremolizzo L., Doueiri M.S., Dong E., Grayson D.R., Davis J., Pinna G., et al. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biological Psychiatry 57 (2005) 500-509
31. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., and Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neuroscience 9 (2006) 519-525
32. Tsujita T., Niikawa N., Yamashita H., Imamura A., Hamada A., Nakane Y., et al. Genomic discordance between monozygotic twins discordant for schizophrenia. American Journal of Psychiatry 155 (1998) 422-424
33. Yoshida M., Horinouchi S., and Beppu T. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17 (1995) 423-430
34. Zarate Jr. C.A., Singh J., and Manji H.K. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biological Psychiatry 59 (2006) 1006-1020